The effect on CV deaths was almost significant in both trials (HR 0.88; 95% CI [0.74–1.05] in DELIVER; HR 0.91; 95% CI [0.76–1.09] in EMPEROR-Preserved).
← all excerpts
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment.
1
—
—